Tamara A Seymour - Net Worth and Insider Trading

Tamara A Seymour Net Worth

The estimated net worth of Tamara A Seymour is at least $6,162 dollars as of 2024-11-13. Tamara A Seymour is the Director of Zevra Therapeutics Inc and owns about 719 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $6,162. Details can be seen in Tamara A Seymour's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tamara A Seymour has not made any transactions after 2023-03-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Tamara A Seymour

To

Tamara A Seymour Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tamara A Seymour owns 4 companies in total, including Viridian Therapeutics Inc (VRDN) , Zevra Therapeutics Inc (ZVRA) , and Kintara Therapeutics Inc (KTRA) among others .

Click here to see the complete history of Tamara A Seymour’s form 4 insider trades.

Insider Ownership Summary of Tamara A Seymour

Ticker Comapny Transaction Date Type of Owner
VRDN Viridian Therapeutics Inc 2015-08-04 CFO & Secretary & Treasurer
ZVRA Zevra Therapeutics Inc 2023-03-17 director
KTRA Kintara Therapeutics Inc 2021-04-29 director
LIMIT LIMIT 2021-03-03 director

Tamara A Seymour Latest Holdings Summary

Tamara A Seymour currently owns a total of 1 stock. Tamara A Seymour owns 719 shares of Zevra Therapeutics Inc (ZVRA) as of March 17, 2023, with a value of $6,162.

Latest Holdings of Tamara A Seymour

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZVRA Zevra Therapeutics Inc 2023-03-17 719 8.57 6,162

Holding Weightings of Tamara A Seymour


Tamara A Seymour Form 4 Trading Tracker

According to the SEC Form 4 filings, Tamara A Seymour has made a total of 2 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 519 shares on March 17, 2023, which cost Tamara A Seymour around $2,502.

Insider Trading History of Tamara A Seymour

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tamara A Seymour Trading Performance

GuruFocus tracks the stock performance after each of Tamara A Seymour's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tamara A Seymour is 16.45%. GuruFocus also compares Tamara A Seymour's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tamara A Seymour within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tamara A Seymour's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tamara A Seymour

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 7.88 LIMIT LIMIT LIMIT LIMIT LIMIT

Tamara A Seymour Ownership Network

Ownership Network List of Tamara A Seymour

No Data

Ownership Network Relation of Tamara A Seymour

Insider Network Chart

Tamara A Seymour Owned Company Details

What does Viridian Therapeutics Inc do?

Who are the key executives at Viridian Therapeutics Inc?

Tamara A Seymour is the CFO & Secretary & Treasurer of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & President and CEO Stephen F. Mahoney , Chief Operating Officer Thomas W. Beetham , and director & other: See Remarks Fairmount Healthcare Fund Ii Gp Llc .

Viridian Therapeutics Inc (VRDN) Insider Trades Summary

Over the past 18 months, Tamara A Seymour made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net sale of 9,796 shares made by Lara Meisner , a net purchase of 1,600,000 shares made by Fairmount Healthcare Fund Ii Gp Llc , and a net purchase of 476,190 shares made by Fairmount Healthcare Fund Gp Llc .

In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 1,626,400 shares, with a net purchase of 1,626,400 shares. During the past 18 months, 9,796 shares of Viridian Therapeutics Inc (VRDN) were sold and 2,102,590 shares were bought by its insiders, resulting in a net purchase of 2,092,794 shares.

Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Viridian Therapeutics Inc Insider Transactions

No Available Data

Tamara A Seymour Mailing Address

Above is the net worth, insider trading, and ownership report for Tamara A Seymour. You might contact Tamara A Seymour via mailing address: C/o Signal Genetics, Inc., 5740 Fleet Street, Carlsbad Ca 92008.